Literature DB >> 17350500

Cutaneous leishmaniasis.

Mark S Bailey1, Diana N J Lockwood.   

Abstract

Cutaneous leishmaniasis is a widespread tropical infection caused by numerous different species of Leishmania protozoa that are transmitted by sandflies. Its clinical presentations are extremely diverse and dependent on a variety of parasite and host factors that are poorly understood. Diagnosis should aim to identify the exact species involved, but this requires laboratory investigations that are not widely available. No single ideal treatment has been identified, and those available are limited by variable success rates and toxicity. Clinical guidelines are needed to make better use of the investigations and treatments that do exist. Prevention is currently limited to bite prevention measures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17350500     DOI: 10.1016/j.clindermatol.2006.05.008

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  68 in total

Review 1.  Leishmaniasis in the United States: treatment in 2012.

Authors:  Henry W Murray
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

2.  Diagnosing Cutaneous leishmaniasis using Fluorescence in Situ Hybridization: the Sri Lankan Perspective.

Authors:  Thilini Dilhara Jayasena Kaluarachchi; Manjula Manoji Weerasekera; Andrew J McBain; Shalindra Ranasinghe; Renu Wickremasinghe; Surangi Yasawardene; Nisal Jayanetti; Rajitha Wickremasinghe
Journal:  Pathog Glob Health       Date:  2019-08-20       Impact factor: 2.894

3.  Isolation and identification of cutaneous leishmaniasis species by PCR-RFLP in Ilam province, the west of Iran.

Authors:  Ali Kermanjani; Lame Akhlaghi; Hormozd Oormazdi; Ramtin Hadighi
Journal:  J Parasit Dis       Date:  2016-04-07

4.  Cutaneous leishmaniasis in travellers: a focus on epidemiology and treatment in 2015.

Authors:  Adrienne J Showler; Andrea K Boggild
Journal:  Curr Infect Dis Rep       Date:  2015-07       Impact factor: 3.725

5.  Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis.

Authors:  Iván Vélez; Liliana López; Ximena Sánchez; Laureano Mestra; Carlos Rojas; Erwin Rodríguez
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

6.  Epidemiological trend of cutaneous leishmaniasis in two endemic focus of disease, south of Iran.

Authors:  Moosa Khosravani; Zahra Nasiri; Davood Keshavarz; Azam Rafat-Panah
Journal:  J Parasit Dis       Date:  2016-01-14

7.  Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment.

Authors:  V Mosimann; A Neumayr; C Hatz; J A Blum
Journal:  Infection       Date:  2013-07-09       Impact factor: 3.553

8.  Isolation and characterization of functional Leishmania major virulence factor UDP-galactopyranose mutase.

Authors:  Michelle Oppenheimer; Ana L Valenciano; Pablo Sobrado
Journal:  Biochem Biophys Res Commun       Date:  2011-03-16       Impact factor: 3.575

Review 9.  Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review.

Authors:  Nahid Maspi; Amir Abdoli; Fathemeh Ghaffarifar
Journal:  Pathog Glob Health       Date:  2016-09-23       Impact factor: 2.894

10.  Effect of elatol, isolated from red seaweed Laurencia dendroidea, on Leishmania amazonensis.

Authors:  Adriana Oliveira Dos Santos; Phercyles Veiga-Santos; Tânia Ueda-Nakamura; Benedito Prado Dias Filho; Daniela Bueno Sudatti; Everson Miguel Bianco; Renato Crespo Pereira; Celso Vataru Nakamura
Journal:  Mar Drugs       Date:  2010-10-29       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.